Rivernorth Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Rivernorth Capital Management’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-56,235	Closed	-$1.15M	–	281
2018 Q4	$1.15M	Hold	56,235	–	–	0.07%	186
2018 Q3	$1.14M	Hold	56,235	–	–	0.1%	124
2018 Q2	$1.12M	Hold	56,235	–	–	0.09%	133
2018 Q1	$1.11M	Sell	56,235 -3,765	-6%	-$73.8K	0.08%	135
2017 Q4	$1.17M	Buy	+60,000	New	+$1.17M	0.08%	127

Other funds holding DMTK

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Rivernorth Capital Management's DMTK Position: Q1 2019 in Review

Rivernorth Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2019, closing a stake of 56,235 shares — an estimated $1.15M sold.

Rivernorth Capital Management first reported a position in DMTK in Q4 2017 and held it in 5 quarters. The position peaked at $1.17M in Q4 2017. 5 funds tracked by Wall St. Rank hold DMTK as of Q1 2019.

Rivernorth Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Rivernorth Capital Management sold 56,235 DermTech, Inc. Common Stock shares in Q1 2019, an estimated $1.15M.
Rivernorth Capital Management first reported a position in DermTech, Inc. Common Stock in Q4 2017 and held it in 5 quarters.
Rivernorth Capital Management's DermTech, Inc. Common Stock position peaked at $1.17M in Q4 2017.
5 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2019.

Based on Rivernorth Capital Management's 13F filing for Q1 2019, filed 15 May 2019.